Myriad Genetics price target lowered to $14 from $24 at Piper Sandler
Piper Sandler analyst David Westenberg lowered the firm’s price target on Myriad Genetics (MYGN) to $14 from $24 and keeps a Neutral rating on ...
Thermo Fisher’s Promising Outlook and Strategic Management Drive Analyst’s Positive Rating
In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price target ...
Pokémon TCG Pocket Gets Space Time Smackdown Expansion Today — Here's Everything You Need to Know
As is the case with every new set release, the addition of Space Time Smackdown has brought new Solo Battles to Pokémon TCG ...
MarketWatch19h
Simon Property Group Inc.
Kimco Realty Corp. Dep. Pfd. (Rep. 1/1000th 5.25% Cum. Redeem. Pfd. Series M) 1.41% Kimco Realty Corp. Dep. Pfd. (Rep. 1/1000th Pfd. Cl L) 1.09% Federal Realty Investment Trust Dep. Pfd. (Rep. 1 ...
MarketWatch19h
Inovio Pharmaceuticals Inc.
Merck & Co. Inc. 0.85% $248.61B ...